US Patent Issued to Merck Sharp & Dohme on May 27 for "Heteroaryl pyrrolidine and piperidine orexin receptor agonists" (New Jersey, Pennsylvania Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,332, issued on May 27, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Heteroaryl pyrrolidine and piperidine orexin receptor agonists" was invented by Stephane L. Bogen (Somerset, N.J.), Ping Chen (Edison, N.J.), Dane James Clausen (Rahway, N.J.), Jinsong Hao (Belle Mead, N.J.), Dipannita Kalyani (Union, N.J.), Michael T. Rudd (Collegeville, Pa.), Shawn P. Walsh (Bridgewater, N.J.), Lan Wei (Berkeley Heights, N.J.) and Dexi Yang (Livingston, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to heteroaryl pyrrolidine and piperidine compounds which are agonists of orexin receptors. The present invention is ...